Algorae Pharmaceuticals Ltd
Company Profile
Business description
Algorae Pharmaceuticals Ltd is a clinical-stage pharmaceutical company developing transformative solutions for undermet medical needs in the community. The firm develops AlgoraeOS, a closed-loop platform, leveraging computational tools to generate novel insights in silico that are being developed to initiate or accelerate therapeutic programs. Its lead products comprise AI-116, a novel combination drug candidate of cannabidiol (CBD) and an off-patent pharmaceutical ingredient. It is conceptualised to be a potential treatment for dementia, including Alzheimer’s disease; NTCELL is an alginate-coated capsule containing clusters of neonatal porcine choroid plexus cells. It also offers LP-003 Anti-obesity Drug and LC-002 migraine treatment.
Contact
201 Sussex Street
Level 16, Tower 2, Darling Park
Sydney NSW 2000
AUST: +61 6492762690
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2024
Employees
48
Stocks News & Analysis
stocks
4 cheap ASX shares owned by top-rated funds
stocks
Is this ASX share still an opportunity after shares jump following strong earnings?
stocks
What next for these 3 high flying ASX shares?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,132.30 | 50.00 | 0.62% |
| CAC 40 | 8,167.50 | 20.99 | -0.26% |
| DAX 40 | 18,704.42 | 34.39 | -0.18% |
| Dow JONES (US) | 40,003.59 | 134.21 | 0.34% |
| FTSE 100 | 8,420.26 | 18.39 | -0.22% |
| HKSE | 19,643.25 | 89.64 | 0.46% |
| NASDAQ | 16,685.97 | 12.35 | -0.07% |
| Nikkei 225 | 39,346.92 | 559.54 | 1.44% |
| NZX 50 Index | 11,711.76 | 11.97 | 0.10% |
| S&P 500 | 5,303.27 | 6.17 | 0.12% |
| S&P/ASX 200 | 7,863.90 | 49.50 | 0.63% |
| SSE Composite Index | 3,162.28 | 8.26 | 0.26% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.00 | -6.60% |
| The Star Entertainment Group Ltd SGR | 0.54 | 0.09 | 19.44% |
| Peninsula Energy Ltd PEN | 0.11 | 0.00 | 0.45% |
| Imugene Ltd IMU | 0.07 | 0.00 | -2.78% |
| Silver Mines Ltd SVL | 0.21 | 0.02 | 9.21% |
| Alligator Energy Ltd AGE | 0.06 | 0.00 | 6.67% |
| Pantoro Ltd PNR | 0.09 | 0.00 | 1.65% |
| South32 Ltd S32 | 3.83 | 0.07 | 1.86% |
| Core Lithium Ltd CXO | 0.16 | 0.01 | -4.55% |
| Lake Resources NL LKE | 0.07 | 0.00 | -4.29% |